Lv523
1150 积分 2024-03-30 加入
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
9天前
已完结
Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease
13天前
已完结
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
15天前
已完结
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
15天前
已完结
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
15天前
已完结
Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
16天前
已完结
DIABETIC ANGIOPATHY
18天前
已完结
Association of high-sensitivity cardiac troponin T with all-cause and cardiovascular mortality in older adults with low lean mass: A 14.6-year longitudinal study
25天前
已完结
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future
1个月前
已完结
Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia‐reperfusion injury by improving mitochondrial quality control: Role of SIRT6
1个月前
已完结
皖公网安备34019202002308
